About 100 reports

  • Biopharmaceuticals Biotechnology Vaccines
  • IV

GenSci' s profitability has been ranked No. ## among Chinese biopharmaceutical companies.

  • Antidiabetics
  • China
  • Demand
  • Market Size
  • Supply

China biopharmaceutical market scale is more than ## trillion Yuan, showing a high speed developing trend.

  • Antidiabetics
  • China
  • Demand
  • Supply
  • Shenzhen Keing Biotech Co., Ltd
  • 12.2 NOVO NORDISK A/S 12.2.1 Key Facts

TABLE ##.

  • Antidiabetics
  • World
  • Forecast
  • Market Size
  • Novo Nordisk Group
  • Global Monoclonal Antibody Sterile Injectables Market

Industry: Biopharmaceutical Website: www. astrazeneca. com About Azoth Analytics Pvt Ltd.

  • Antidiabetics
  • World
  • Market Size
  • Baxter International Inc.
  • Gilead Sciences, Inc.

The company has been recognized as a group leader in the pharmaceuticals, biotechnology, life sciences industries continuously for nine consecutive years by the Dow Jones Sustainability Indices (DJSI).

  • Antidiabetics
  • Diabetes
  • Insulin Delivery
  • Pharmaceutical
  • Therapy

Patented products. ##.

  • Antidiabetics
  • North America
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • REVENUE BREAKDOWN (%), BY OPERATING SEGMENT, 2018

THE FIRM ALSO PROVIDES FUNDING FOR BIOPHARMACEUTICAL RESEARCH.

  • Antidiabetics
  • Canada
  • North America
  • AstraZeneca PLC
  • Becton Property Group
  • BIOTON FORMS JOINT VENTURE WITH ACTAVIS GROUP
  • BIOTON ENTERS INTO DISTRIBUTION AGREEMENT WITH BIOMM

GlobalData Bioton SA reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Antidiabetics
  • Deals & Alliance
  • M&A
  • Supply
  • Bioton S.A.
  • 7.1 Licensing deals
  • DIABETES DRUGS MARKET, GLOBAL, LICENSING DEALS VALUED AT $100M AND

This related to a licensing agreement between Array BioPharma and Amgen for Array BioPharma' s small molecule glucokinase activator program.

  • Antidiabetics
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.
  • Johnson & Johnson

ADC is one such approach.

  • Antidiabetics
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

KEY COMPANIES COVERED ##.

  • Antidiabetics
  • Western Europe
  • Forecast
  • Insulet Corporation
  • Medtronic, Inc.

China Phone :( ##) ## Chapter VII Fax :( ##) ## E-mail: infochina@novonordisk. com INSULIN PRODUCER DIRECTORY Company Overview-Novo Nordisk is one of the world' s leading bio-pharmaceutical companies and the world leader in insulin production for diabetes treatment

  • Antidiabetics
  • China
  • Demand
  • Market Size
  • Eli Lilly & Co.

GLP-## receptor agonists can be classified into short-acting and long-acting GLP-## receptor agonists.

  • Antidiabetics
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • MARKET ANALYSIS 2016

Also, it is estimated that one-third of all the adults and one-sixth of the children and adolescents in the US are obese.

  • Antidiabetics
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.

Global Biosimilar Insulin Market Opportunity & Clinical Insight Outlook 2022 ##.

  • Antidiabetics
  • Biosimilar
  • Medical Biotechnology
  • World
  • Market Size
  • 10.3.2 NOVO NORDISK

Biopharmaceutics & of the Japan Medical Association; ##(##): ##-## Atherosclerosis Reports; ##(##): ##.

  • Antidiabetics
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

China Phone :( ##) ## Chapter VII Fax :( ##) ## E-mail: infochina@novonordisk. com INSULIN PRODUCER DIRECTORY Company Overview-Novo Nordisk is one of the world' s leading bio-pharmaceutical companies and the world leader in insulin production for diabetes treatment

  • Antidiabetics
  • China
  • Eli Lilly & Co.
  • Hangzhou Sanofi Aventis Minsheng Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.

The drug candidate acts by targeting LRH-##/ NR##A##.

  • Antidiabetics
  • Diabetes
  • Insulin
  • Therapy
  • World

Note: ##.

  • Antidiabetics
  • Northern Europe
  • Scandinavia
  • Western Europe
  • Forecast

##.

  • Antidiabetics
  • Market Size
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.

##.

  • Antidiabetics
  • East Asia
  • Market Size
  • B. Braun Melsungen AG
  • Eli Lilly & Co.
  • Corporate Profile
  • Business Segment Analysis

IT OPERATES IN TWO SEGMENTS: DIABETES CARE AND BIOPHARMACEUTICALS.

  • Antidiabetics
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited
  • Scope of the report
  • Vendor landscape

In August 2015, the company planned to acquire two biopharmaceutical research companies, Calibrium and MB##.

  • Antidiabetics
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Sanofi S.A.

Sweden ##.

  • Antidiabetics
  • Northern Europe
  • Western Europe
  • Forecast
  • Roche Group
  • CORPORATE ANALYSIS

CONTACT DETAILS: INTAS BIOPHARMACEUTICALS LTD.

  • Antidiabetics
  • Biosimilar
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.

Insulin Market Analysis By Product, By Segments, By Application And Segment Forecasts To 2020 Table of Contents Chapter ##.

  • Antidiabetics
  • Insulin
  • United States
  • World
  • Market Size

INTRODUCTION.............. ## ##.

  • Antidiabetics
  • China
  • India
  • World
  • Market Shares
  • Negatives

Afrezza, produced by biopharmaceutical company MannKind and promoted by Sanofi, is mealtime insulin that is inhaled at the time one has a meal.

  • Antidiabetics
  • Injectable Delivery
  • Insulin
  • Insulin Delivery
  • Medical Device
  • BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014
  • Novo Nordisk

Diabetes care Biopharmaceuticals BIOPHARMACEUTICAL ##% DIABETES CARE ##% Source: Technavio, 2015 BUSINESS SEGMENTATION BY REVENUE 2013 AND 2014 $billions DIABETES CARE 2013 2014 BIOPHARMACEUTICALS In FY2014, the revenue increased by ##% compared to that in 2013.

  • Antidiabetics
  • Diabetes
  • Insulin
  • Recombinant Insulin
  • Lilly Endowment Inc.
  • PIPELINE BY NUSIRT BIOPHARMA INC, H2 2018
  • MAY 18, 2016: NUSIRT BIOPHARMA TO PRESENT AT AMERICAN DIABETES ASSOCIATION'S 76TH SCIENTIFIC SESSIONS

NUSIRT BIOPHARMA INC PIPELINE BY NUSIRT BIOPHARMA INC, H## 2018 (ACAMPROSATE + RIBAVIRIN) - DRUG PROFILE NAD Dependent Protein Deacetylase Sirtuin ## (SIR## Like Protein ## or Sirtuin Type ## or Regulatory Protein SIR## Homolog ## or SIRT## or EC ##. ##. ##.

  • Antidiabetics
  • Pharmaceutical
  • United States
  • World
  • GlaxoSmithKline plc